Cellebrite DI Ltd
New SaaS delivery transforms access, collection and analysis of data from a wide variety of remote devices across the enterprise with unparalleled efficiency and consent-based security
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Investigative solutions, today unveils Cellebrite Endpoint Inspector SaaS. This enhanced delivery model of our industry-leading Endpoint Inspector product offers enterprise customers and eDiscovery service providers next-generation digital forensic capabilities that enable the streamlined collection and analysis of data from diverse remote devices, all within a unified, consent-based, secure framework.
With Cellebrite’s evolving suite of SaaS solutions in its Case-to-Closure platform, organizations can now quickly deploy seamless, targeted remote data collection for faster acquisition of critical information, reducing time-to-data from days to minutes. This includes enabling examiners to retrieve Cloud messaging in cooperation with custodians. The solution complements Cellebrite’s SaaS usage-based offering for mobile data collection in the private sector, Endpoint Mobile Now. As a top-tier provider for eDiscovery professionals, Endpoint Inspector SaaS offers organizations a centralized platform for real-time visibility into collection statuses. This efficiency eliminates the need for multiple tools or manual tracking in spreadsheets, while its automatic updates for new device software versions mitigate the risks tied to frequent device upgrades.
"With the rapid adoption of SaaS solutions, it's critical that our systems not only stay ahead of technological advancements but also adhere to the highest ethical and legal standards," says Ronnen Armon, Chief Products Technologies Officer at Cellebrite. "Cellebrite Endpoint Inspector SaaS is at the forefront of this, ensuring examiners can efficiently collect data from a range of devices, irrespective of location, without managing software or compromising on consent and security."
Cellebrite is dedicated to leading the industry not just in technological innovation but also in ethical practices. The Endpoint Inspector SaaS operates strictly within a consent-based framework, ensuring all activities are transparent and authorized by device owners. This approach is fundamental to our values and is embedded in every aspect of our solution.
For More Information:
Discover how Cellebrite Endpoint Inspector SaaS can transform your enterprise data collection and analysis. Visit us at https://enterprise.cellebrite.com/Cellebrite-endpoint-inspector/
About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigative platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on X at @Cellebrite.
About Cellebrite Enterprise Solutions
In a world that’s evolving rapidly, Cellebrite Enterprise Solutions looks beyond the horizon to design solutions to keep data within reach, transform it and reveal important insights to protect your business and employees. From headquarters to home office, eDiscovery professionals and corporate investigators can access endpoints anywhere with Cellebrite’s enterprise solution offerings.
Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910
Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Financière de Tubize SA26.4.2025 08:00:00 CEST | Press release
Financière de Tubize - Dividend approval
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom